From overtreatment to precision: a new clinical standard for DCIS management

Key Points

• The aim is to redefine management approaches for ductal carcinoma in situ, focusing on precision rather than overtreatment.
• Conducted a literature review on DCIS diagnosis and treatment approaches.
• Analyzed current clinical standards and their implications for patient outcomes.
• Evaluated the biological characteristics of DCIS and its impact on treatment decisions.
• Highlighted the non-invasive nature of DCIS and its limited metastatic potential.
• Demonstrated that the labeling of DCIS as 'breast cancer' may lead to unnecessary overtreatment.
• Suggested precision management strategies that could reduce patient anxiety and improve quality of care.

Abstract